Nutritional supplements that may be helpful: Many years ago,
researchers studied the effects of vitamin E
supplementation in reducing symptoms of menopause. Most,12 13
14 15 16 but not all,17 studies found vitamin E to be
helpful. Many doctors suggest that women going through menopause take 800 IU per day of
vitamin E for a trial period of at least three months to see if symptoms are reduced. If
helpful, this amount may be continued. Using lower amounts for less time has led to
statistically significant changes, but only marginal clinical improvement.18
In 1964, a preliminary trial reported that 1,200 mg each of vitamin C and the flavonoid,
hesperidin, taken over the course of the day helped relieve hot flashes.19 Although
placebo effects are strong in women with hot flashes, other treatments used in that trial
failed to act as effectively as the flavonoid/vitamin C combination. Since then, researchers
have not explored the effects of flavonoids or vitamin C in women with menopausal
symptoms.
The mineral boron is known to affect estrogen metabolism.
In one double-blind trial using 2.5 mg of boron per day for two months, hot flashes and night
sweats worsened in 21 of 43 women, but the same symptoms improved in ten others.20
Women who are experiencing hot flashes or night sweats that have been diagnosed as menopausal
symptoms and who are also supplementing boron (sometimes found in significant amounts in osteoporosis formulas and multivitamin-mineral supplements) should consider
discontinuing use of boron-containing supplements to see if the severity of their symptoms is
reduced.
Aging in women is characterized by a progressive decline in blood DHEA
(dehydroepiandrosterone) and DHEA-sulfate (DHEAS) levels. These levels can be restored with DHEAsupplementation. This process also improves the response of
some brain chemicals, called endorphins, to certain drugs.21 These endorphins are
involved in sensations of pleasure and pain; improving their
response may explain why DHEA has an effect on mood symptoms associated with menopause. In one
double-blind trial, however, menopausal women who took 50 mg of DHEA per day for three months
had no improvement in symptoms compared with women taking placebo.22 Further study
is needed to validate a role for DHEA in the management of menopausal symptoms.
Natural progesterone supplementation has been
anecdotally linked to reduction in symptoms of menopause.23 24
25 In one trial, natural progesterone was found to have no independent effect on
symptoms, and synthetic progestins were found to
increase breast tenderness.26 However, a double-blind trial found that topical
administration of natural progesterone cream led to a reduction in hot flashes in 83% of
women, compared with improvement in only 19% of those given placebo.27 Preliminary
research has found that oral, micronized progesterone therapy is associated with improved
quality of life among postmenopausal women. However, oral micronized progesterone is available
only by prescription in the United States.28 Hot flashes, anxiety, depression,
sleep problems, and sexual functioning were among the symptoms improved in a majority of women
surveyed. Synthetic progestins, also available only by prescription, have reduced symptoms of
menopause.29 30 31
Progesterone is a hormone and, as such, concerns about its inappropriate use (i.e., as an
over-the-counter supplement) have been raised. The amount of progesterone in commercially
available creams varies widely, and the progesterone content is not listed on the label
because the creams are legally regulated as cosmetics, not dietary supplements. Therefore, a
physician should be consulted before using these hormone-containing creams as supplements.
Although few side effects have been associated with topical progesterone creams, skin
reactions may occur in some users. Effects of natural progesterone on breast cancer risk remain unclear; research has suggested
both increased and reduced risk.
Are there any side effects or interactions? Refer to the individual supplement for
information about any side effects or interactions.
Herbs that may be helpful: Double-blind trials support the
usefulness of black cohosh for women with hot flashes
associated with menopause.32 A review of eight trials concluded black cohosh to be
both safe and effective.33 Many doctors recommend 20 mg of a highly concentrated
extract taken twice per day; 2–4 ml of tincture three times per day may also be
used.
In a double-blind trial, a standardized kava extract was
found to be effective at reducing anxiety and other
symptoms associated with menopause (see warning in this section).34 The study used
100 mg of kava extract standardized to contain 70% kava-lactones, three times per day. Most
commercially available kava extracts contain up to 35% kava-lactones. In another study,
administration of kava enhanced the anti-anxiety effect of hormone replacement therapy in
postmenopausal women.35
Warning: Reports from late 2001 have indicated that kava may be
associated with liver damage.36 37 38 39
40 Until additional information clarifies the extent of the risk involved, it is
strongly recommended that all individuals consult their physician before taking kava. In
addition, based on the available information, it seems that people with liver disease and
those taking medications that have the potential to damage the liver should not take kava.
A variety of herbs with weak estrogen-like actions similar to the effects of soy have
traditionally been used for women with menopausal symptoms.41 These herbs include
licorice, alfalfa, and red clover. In a double-blind trial, a formula containing
tinctures of licorice, burdock, dong quai, wild yam, and motherwort (30 drops three times daily) was found to reduce
symptoms of menopause.42 No effects on hormone levels were detected in this study.
In a separate double-blind trial, supplementation with dong quai (4.5 grams three times daily
in capsules) had no effect on menopausal symptoms or hormone levels.43 A
double-blind trial using a standardized extract of subterranean clover (Trifolium
subterraneum), a relative of red clover, containing
40 mg isoflavones per tablet did not impact symptoms of menopause, such as hot flashes, though
it did improve function of the arteries.44
Sage may reduce excessive perspiration due to menopausal hot
flashes during the day or at night.45 It is believed this is because sage directly
decreases production of sweat. This is based on traditional herbal prescribing and has not
been evaluated in clinical studies
Blue vervain (Verbene hastata) is a traditional herb for menopause; however, there
is no research to validate this use. Tincture has been recommended at an amount of 5–10
ml three times per day.
Preliminary evidence suggests that supplementation with St. John’s wort extract (300 mg three times daily for 12
weeks) may improve psychological symptoms, including sexual well-being, in menopausal
women.46
A double-blind trial found that Asian ginseng (200
mg per day of standardized extract) helped alleviate psychological symptoms of menopause, such
as depression and
anxiety, but did not decrease physical symptoms, such as hot flashes or sexual
dysfunction, in postmenopausal women who had not been treated with hormones.47
Are there any side effects or interactions? Refer to the individual herb for
information about any side effects or interactions.
References:
1. Baird DD, Umbach DM, Landsedell L, et al. Dietary intervention study
to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol
Metab 1995;80:1685–90.
2. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy
protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin
Nutr 1994;60:333–40.
3. Knight DC, Eden JA. A review of the clinical effects of
phytoestrogens. Obstet Gynecol 1996;87:897–904 [review].
4. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary
soy supplementation on hot flushes. Obstet Gynecol 1998;91:6–11.
5. Albertazzi P, Pansini F, Bottazzi G, et al. Dietary soy
supplementation and phytoestrogen levels. Obstet Gynecol 1999;94:229–31.
6. Brezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of
phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89–94.
7. Ivarsson T, Spetz AC, Hammar M. Physical exercise and vasomotor
symptoms in postmenopausal women. Mauritas 1998;29:139–46.
8. Hammar M, Berg G, Lindgren R. Does physical exercise influence the
frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand
1990;69:409–12.
9. Slaven L, Lee C. Mood and symptom reporting among middle-aged women:
the relationship between menopausal status, hormone replacement therapy, and exercise
participation. Health Psychol 1997;16:203–8.
10. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal
hot flashes. J Womens Health 1998;7:1149–55.
11. Greenberg G, Thompson SG, Meade TW. Relation between cigarette
smoking and use of hormonal replacement therapy for menopausal symptoms. J Epidemiol
Community Health 1987;41:26–9.
12. Perloff WH. Treatment of the menopause. Am J Obstet Gynecol
1949;58:684–94.
13. Gozan HA. The use of vitamin E in treatment of the menopause. NY
State J Med 1952;52:1289.
14. Christy CJ. Vitamin E in menopause: Preliminary report of
experimental and clinical study. Am J Obstet Gynecol 1945:50:84.
15. Finkler RS. The effect of vitamin E in the menopause. J Clin
Endocrinol Metab 1949;9:89–94.
16. Rubenstein BB. Vitamin E diminishes the vasomotor symptoms of
menopause. Fed Proc 1948;7:106 [abstract].
17. Blatt MHG, Weisbader H, Kupperman HS. Vitamin E and climacteric
syndrome: failure of effective control as measured by menopausal index. Arch Intern
Med 1953;91:792–9.
18. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of
vitamin E for hot flashes in breast cancer survivors. J Clin Oncol
1998;16:495–500.
19. CJ Smith. Non-hormonal control of vaso-motor flushing in menopausal
patients. Chicago Med 1964;67:193–5.
20. Nielsen FH, Penland JG. Boron supplementation of per-menopausal women
affects boron metabolism and indices associated with macromineral metabolism, hormonal status
and immune function. J Trace Elements Exp Med 1999;12:251–61.
21. Stomati M, Rubino S, Spinetti A, et al. Endocrine, neuroendocrine and
behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal
women. Gynecol Endocrinol 1999;13:15–25.
22. Barnhart KT, Freeman E, Grisso JA, et al. The effect of
dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine
profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol
Metab 1999;84:3896–902.
23. Lee JR. Natural Progesterone. The multiple roles of a remarkable
hormone. Sebastipol, CA: BLL Publishing, 1993, 31–7.
24. Gaby AR. Commentary. Nutr Healing
1996;June:1,10–1.
25. Wright JV. Hormones for menopause. Nutr Healing
1996;June:1–2,9.
26. Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side
effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin
Interventions Trial. Obstet Gynecol 1998;92:982–8.
27. Leonetti HB, Long S, Anasti JM. Transdermal progesterone cream for
vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol
1999;94:225–8.
28. Fitzpatrick LA, Pace C, Wiita B. Comparison of regimens containing
oral micronized progesterone or medroxyprogesterone acetate on quality of life in
postmenopausal women: a cross-sectional survey. J Women’s Health Gender-Based
Med 2000;9:381–7.
29. Bullock JL, Massey FM, Gambrell RD Jr. Use of medroxyprogesterone
acetate to prevent menopausal symptoms. Obstet Gynecol 1975;46:165–8.
30. Morrison JC, Martin DC, Blair RA, et al. The use of
medroxyprogesterone acetate for relief of climateric symptoms. Am J Obstet Gynecol
1980 138:99–104.
31. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone
in the treatment of postmenopausal symptoms. JAMA 1980;244:1443–5.
32. Liske E. Therapeutic efficacy and safety of Cimicifuga
racemosa for gynecological disorders. Advances Therapy 1998;15:45–53.
33. Lieberman S. A review of the effectiveness of Cimicifuga
racemosa (black cohosh) for the symptoms of menopause. J Womens Health
1998;7:525–9.
34. Warnecke G. Psychosomatic dysfunctions in the female climacteric.
Clinical effectiveness and tolerance of kava extract WS 1490. Fortschr Med
1991;119–22 [in German].
35. De Leo V, la Marca A, Morgante G, et al. Evaluation of combining kava
extract with hormone replacement therapy in the treatment of postmenopausal anxiety.
Maturitas 2001;39:185–8.
36. Stafford, Ned. Germany may ban kava kava herbal supplement.
Reuters, Nov. 19, 2001. http://www.reutershealth.com/frame2/eline.html
37. Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with
kava, a herbal remedy for anxiety. BMJ 2001;322:139.
38. Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after
administration of the herbal antidepressant Kava-Kava. Dtsch Med Wochenschr
2001;126:970–2 [in German].
39. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after
taking herbal remedies. Dtsch Med Wochenschr 1998;123:1410–4 [in German].
40. Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity. Ann
Intern Med 2001;135:68–9 [letter].
41. Crawford AM. The Herbal Menopause Book. Freedom, CA:
Crossing Press, 1996.
42. Hudson TS, Standish L, Breed C, et al. Clinical and endocrinological
effects of a menopausal botanical formula. J Naturopathic Med
1997;7(1):73–7.
43. Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic
effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil
Steril 1997;68:981–6.
44. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover
improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin
Endocrinol Metab 1999;84:895–8.
45. Duke JA. CRC Handbook of Medicinal Herbs. Boca Raton, FL:
CRC Press, 1985, 420–1 [review].
46. Grube B, Walper A, Wheatley D. St. John’s Wort extract:
efficacy for menopausal symptoms of psychological origin. Adv Ther
1999;16:177–86.
47. Wiklund IK, Mattson LA, Lindgren R, et al. Effects of a standardized
ginseng extract on quality of life and psychological parameters in symptomatic postmenopausal
women: a double-blind, placebo-controlled trial. Int J Clin Pharm Res
1999;19:89–99.
48. Toriizuka K, Okumura M, Iijima K, et al. Acupuncture inhibits the
decrease in brain catecholamine contents and the impairment of passive avoidance task in
ovariectomized mice. Acupunct Electrother Res 1999;24:45–57.
49. Wyon Y, Lindgren R, Hammar M, Lundeberg T. Acupuncture against
climacteric disorders? Lower number of symptoms after menopause. Lakartidningen
1994;91:2318–22 [in Swedish].
50. Popivanov P. Menopausal indices as criteria for the effectiveness of
acupuncture treatment of the climacteric syndrome. Vutr Boles 1983;22:110–3 [in
Bulgarian].
51. Kraft K, Coulon S. Effect of a standardized acupuncture treatment on
complaints, blood pressure and serum lipids of hypertensive, postmenopausal women. A
randomized, controlled clinical study. Forsch Komplementarmed 1999;6:74–9 [in
German].
52. Lianzhong W, Xin Z. 300 cases of menopausal syndrome treated by
acupuncture. J Trad Chin Med 1998;18:259–62.